Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA

Abstract

This research demonstrates that a glycan biomarker could have value to detect chemotherapy-resistant PDAC in clinical settings. This capability could aid in the development of stratified treatment plans and facilitate biomarker-guided trials targeting resistant PDAC.